"Hyperphosphatemia in Chronic Kidney Disease - Pipeline Review, H2 2012" Published
Global Markets Direct's, 'Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hyperphosphatemia In Chronic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperphosphatemia In Chronic Kidney Disease. Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, Half Year is built using data and information sourced...
View full press release